Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

DKK3 is a potential tumor suppressor gene in papillary thyroid carcinoma.

Yin DT, Wu W, Li M, Wang QE, Li H, Wang Y, Tang Y, Xing M.

Endocr Relat Cancer. 2013 Jun 27;20(4):507-14. doi: 10.1530/ERC-13-0053. Print 2013 Aug.

PMID:
23702469
[PubMed - indexed for MEDLINE]
Free Article
2.

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.

Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.

Breast Cancer Res. 2008;10(5):R82. doi: 10.1186/bcr2151. Epub 2008 Sep 30.

PMID:
18826564
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer.

Hu S, Liu D, Tufano RP, Carson KA, Rosenbaum E, Cohen Y, Holt EH, Kiseljak-Vassiliades K, Rhoden KJ, Tolaney S, Condouris S, Tallini G, Westra WH, Umbricht CB, Zeiger MA, Califano JA, Vasko V, Xing M.

Int J Cancer. 2006 Nov 15;119(10):2322-9.

PMID:
16858683
[PubMed - indexed for MEDLINE]
4.

Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.

Boltze C, Schneider-Stock R, Quednow C, Hinze R, Mawrin C, Hribaschek A, Roessner A, Hoang-Vu C.

Int J Mol Med. 2003 Oct;12(4):479-84.

PMID:
12964023
[PubMed - indexed for MEDLINE]
5.

[Relationship between methylation status of promoter and expression of XAF1 gene in papillary thyroid carcinoma].

Yin DT, Chen G, Li HQ, Zheng XY, Wang YF, Zhang Y, Jiang JH, Wang QD.

Zhonghua Yi Xue Za Zhi. 2012 Jul 24;92(28):1967-70. Chinese.

PMID:
22944270
[PubMed - indexed for MEDLINE]
6.

[Methylation and expression of RUNX3 gene promoter in papillary thyroid carcinoma].

Yin DT, Cao SL, Wang YF, Li HQ, Zhou YB, Zheng LY, Jiang JH, Wang QD.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 May;46(5):417-9. Chinese.

PMID:
21781566
[PubMed - indexed for MEDLINE]
7.

Quantitative assessment of RASSF1A methylation as a putative molecular marker in papillary thyroid carcinoma.

Kunstman JW, Korah R, Healy JM, Prasad M, Carling T.

Surgery. 2013 Dec;154(6):1255-61; discussion 1261-2.

PMID:
24383114
[PubMed - indexed for MEDLINE]
8.

Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.

Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R.

Cancer Res. 2002 Jul 1;62(13):3698-701.

PMID:
12097277
[PubMed - indexed for MEDLINE]
Free Article
9.

Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.

Li JY, Han C, Zheng LL, Guo MZ.

Chin Med J (Engl). 2012 Oct;125(19):3526-31.

PMID:
23044318
[PubMed - indexed for MEDLINE]
10.

Methylation of p16 CpG islands correlated with metastasis and aggressiveness in papillary thyroid carcinoma.

Wang P, Pei R, Lu Z, Rao X, Liu B.

J Chin Med Assoc. 2013 Mar;76(3):135-9. doi: 10.1016/j.jcma.2012.11.007. Epub 2013 Jan 23.

PMID:
23497965
[PubMed - indexed for MEDLINE]
11.

Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.

Lam AK, Lo CY, Leung P, Lang BH, Chan WF, Luk JM.

Ann Surg Oncol. 2007 May;14(5):1772-9. Epub 2006 Dec 31.

PMID:
17195959
[PubMed - indexed for MEDLINE]
12.

[Aberrant methylation of hMLH1 gene promoter in papillary thyroid cancer and its clinical significance].

Lu XX, Ge MH, Ling ZQ, Hu SS, Xu J, Zheng CM, Tan Z, Chen C.

Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):833-6. Chinese.

PMID:
24447481
[PubMed - indexed for MEDLINE]
13.

Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway.

Fu J, Lv H, Guan H, Ma X, Ji M, He N, Shi B, Hou P.

BMC Cancer. 2013 Oct 8;13:462. doi: 10.1186/1471-2407-13-462.

PMID:
24098937
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.

Gu YM, Ma YH, Zhao WG, Chen J.

World J Gastroenterol. 2011 Sep 7;17(33):3810-7. doi: 10.3748/wjg.v17.i33.3810.

PMID:
21987623
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer.

Guan H, Ji M, Hou P, Liu Z, Wang C, Shan Z, Teng W, Xing M.

Cancer. 2008 Jul 15;113(2):247-55. doi: 10.1002/cncr.23548.

PMID:
18470905
[PubMed - indexed for MEDLINE]
Free Article
16.

[Transcription and promoter hypermethylation of thyroid stimulating hormone receptor gene in human papillary thyroid carcinoma].

Dai YL, Cai DH, Chen H, Zhang Y, Li J.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jan;30(1):114-7. Chinese.

PMID:
20117998
[PubMed - indexed for MEDLINE]
Free Article
17.

Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma.

Ferrario C, Lavagni P, Gariboldi M, Miranda C, Losa M, Cleris L, Formelli F, Pilotti S, Pierotti MA, Greco A.

Lab Invest. 2008 May;88(5):474-81. doi: 10.1038/labinvest.2008.17. Epub 2008 Mar 10.

PMID:
18332874
[PubMed - indexed for MEDLINE]
Free Article
18.

Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer.

Sassa M, Hayashi Y, Watanabe R, Kikumori T, Imai T, Kurebayashi J, Kiuchi T, Murata Y.

Thyroid. 2011 May;21(5):511-7. doi: 10.1089/thy.2010.0295. Epub 2011 Mar 30.

PMID:
21449767
[PubMed - indexed for MEDLINE]
19.

Beclin 1 is highly expressed in papillary thyroid carcinoma and correlates with lymph node metastasis.

Li X, Xu H, Ma H.

Acta Chir Belg. 2013 May-Jun;113(3):175-81.

PMID:
24941712
[PubMed - indexed for MEDLINE]
20.

Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.

Veeck J, Wild PJ, Fuchs T, Schüffler PJ, Hartmann A, Knüchel R, Dahl E.

BMC Cancer. 2009 Jul 1;9:217. doi: 10.1186/1471-2407-9-217.

PMID:
19570204
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk